Core Viewpoint - Enzyme Science is recognized for its innovative contributions to biomanufacturing, particularly in the development of chiral amines, and aims to lead advancements in synthetic biology and green manufacturing [2][3]. Group 1: Awards and Recognition - Enzyme Science's project on "Key Technology Innovation and Industrialization Demonstration of Biomanufacturing of Chiral Amines with Cyclic Structures" won the second prize of the 2024 Zhejiang Provincial Science and Technology Progress Award [2]. - The company has received multiple honors, including being recognized as a high-tech enterprise and a "little giant" in specialized and innovative sectors [3]. Group 2: Technological Innovations - The company utilizes protein crystallography and computational biology to reconstruct ancestral sequences and analyze the crystal structure of transaminases, enhancing enzyme stability, activity, and substrate universality [2]. - Enzyme Science has developed a "green biosynthesis - product precise separation - multi-category chiral amine large-scale manufacturing" technology system, achieving high-purity production of various chiral amines [2]. Group 3: Research and Development Efficiency - The establishment of the EnzyAI virtual computing platform has significantly improved R&D efficiency, allowing one person to achieve what previously required a team of five over several months [5]. - The number of new products developed annually has increased from two to over ten [5]. Group 4: Collaborations and Partnerships - Enzyme Science has formed partnerships with institutions like Shenzhen University of Technology to create a predictive and programmable intelligent biomanufacturing platform [5][7]. - The company is also collaborating with teams to explore marine extremophilic microbial enzyme resources and AI-assisted design [7]. Group 5: Commercialization and Market Reach - Enzyme Science has commercialized over 20 products across various sectors, including pharmaceutical intermediates and food additives, with expectations of doubling revenue this year [7]. - The company serves major global pharmaceutical firms such as AstraZeneca, Bayer, and Merck, contributing to significant medications for conditions like high cholesterol and diabetes [8]. Group 6: Future Plans and IPO - Enzyme Science plans to initiate an IPO in early 2026, with a Pre-IPO financing round aimed at expanding production capacity and enhancing cash flow, expecting a valuation exceeding 1.5 billion [8]. - The company aims to extend its applications beyond pharmaceuticals and food into sectors like new energy vehicles and textiles, contributing to carbon neutrality goals [8].

Group 1 - The Inner Mongolia Autonomous Region government is implementing a "1571" work deployment to promote high-quality development [1] - In 2026, Inner Mongolia will launch a technology innovation plan aimed at addressing key common technical issues in various industries [3] - The plan includes major projects in rare earth materials, seed engineering, and focuses on upgrading and strengthening advantageous industries [3] Group 2 - There will be an emphasis on cultivating emerging and future industries, particularly in low-altitude economy, "AI+", and biomanufacturing [3] - Increased support for basic research will be provided, with a focus on application-oriented approaches to solidify the foundation of technological innovation [3] - Research will also address public concerns, including ecological protection and pollen allergy prevention [3]

为更好地推动科技金融与科技产业化的发展，对母基金在中国资本市场里所发挥的重要作用进 行系统研究，发挥政府出资产业投资基金等的资源和战略优势，加强政府对社会资本的管理和 引导，促进社会资本流向创新创业型企业和实体经济，推动中国投资行业特别是母基金行业的 健康发展， "中国国际科技促进会母基金分会"（简称"科促会母基金分会"）成立。科促会母基 金分会领导班子所在机构及参会机构 共 8 7 家，科促会母基金分会于每周二更新相关机构的一 周资讯。 01 这支长三角母基金招GP了 为规范、高效地遴选长三角生态绿色一体化发展示范区投资基金（以下简称 "示范区投资基 金"或"母基金"）的子基金管理机构，根据《长三角生态绿色一体化发展示范区投资基金管理 办法》（以下简称《办法》）等相关规定，遵循公开、公平、公正的原则，现面向社会公开遴 选子基金管理机构。 有关事项公告如下：一、遴选基本原则 （一）公开公平公正原则。遴选过程面向社会公开发布、程序规范透明、条件标准统一，保障 各类申报机构平等参与，确保客观公正。（二）依法依规审慎原则。严格遵循法律法规、行业 监管规定以及《办法》等制度要求，规范履行评审、决策程序，加强风险识别与 ...

Group 1: Core Perspectives - The emphasis on technology as the primary productivity force, talent as the primary resource, and innovation as the primary driving force is highlighted, with a focus on aligning with national strategic technology initiatives and enhancing international cooperation [1] - The goal is to build a distinctive highland for technological innovation, reform, and open cooperation, aiming to create a regional technology innovation center [8] Group 2: Technological Innovation Highland - Hainan is focusing on creating a globally influential technology innovation center by developing regional innovation systems that support high-quality local development [2] - The province has seen a significant increase in R&D funding, with a growth rate that has been the highest in the country for three consecutive years, and the number of national-level innovation platforms has doubled to 25 [2] - Hainan's comprehensive technology innovation index has improved, moving up six places to rank in the second tier nationally [2] Group 3: Integration of Technology and Industry - The strategy includes deep integration of technological innovation with industrial innovation, focusing on five key areas: agriculture, marine, aerospace, green technology, and digital technology [3] - The aim is to enhance the role of enterprises in technological innovation, fostering high-tech companies and unicorns through organized research and development [3] Group 4: Reforming the Technology System - Hainan is advancing reforms in the technology system, including optimizing management mechanisms and enhancing the collaborative innovation between government, industry, academia, and finance [4][5] - The province is implementing a series of institutional innovations to improve the efficiency of technology transfer and commercialization [5] Group 5: Open Cooperation in Technology - Hainan is actively engaging in international technology cooperation, establishing partnerships with 54 countries and regions, and hosting various international technology exchange events [6][7] - The province aims to leverage its unique advantages as a free trade port to attract innovative resources and enhance the internationalization of its technology work [7] Group 6: Talent Development - The construction of a "talent-rich island" and "technology innovation island" is a strategic task for the high-standard development of Hainan Free Trade Port, emphasizing the importance of talent in achieving these goals [8]

Core Insights - The article emphasizes the transformative role of synthetic biology in reshaping the chemical industry towards a green and low-carbon future, with Anhui Huaheng Biotechnology Co., Ltd. as a leading player in this change [1][2]. Group 1: Company Leadership and Strategy - Guo Henghua, the chairman and general manager of Huaheng Biotechnology, has successfully positioned the company as a leader in the amino acids and bio-based products sector through keen market insights and technical expertise [1]. - The company adopts an "engineering mindset" throughout the product development and industrialization process, ensuring a seamless transition from laboratory breakthroughs to market-ready products [1][2]. Group 2: Technological Advancements and Industrialization - After initial technological breakthroughs in amino acids, the company focused on pilot testing and scaling up to address critical issues such as stability, batch consistency, and cost control, leading to long-term stable operation of industrial facilities [2]. - The research team enhances production efficiency and yield by optimizing fermentation processes and purification methods, ensuring a stable market supply of bio-based materials and functional raw materials [2]. Group 3: Global Market Position and Collaboration - Under Guo Henghua's long-term strategic vision, Huaheng Biotechnology maintains a leading position in the global market and continues to expand its core role in the international supply chain [2]. - The company has established partnerships with multiple international firms, broadening its overseas market presence and solidifying its position within the global bio-manufacturing industry [2]. Group 4: Future Outlook - As synthetic biology technology continues to evolve, the company aims to explore pathways for high-quality development in China's bio-manufacturing sector and contribute to the high-quality growth of the chemical economy [3].

昨日指数高开高走，最终仅创指收涨，两市成交量小幅放量。整体来看指数放量收复5日均线，且KDJ金 叉，意味着主板重回多头局面。既然如此，那么本周指数就会安稳一周，个股们在最后一周，也能普遍弱 反一些，可继续持股待涨。操作上建议低吸参与为主。 ★涉及两大战略新兴产业 充电机器人国家标准启动编制 我国首个电动汽车充电机器人国家标准《机器人 性能规范及其试验方法 第8部分：电动汽车充电机器人》 近日正式启动编制。该标准由国网天津电科院牵头申报，编制完成后将填补我国在该领域的测试标准空 白，标志着我国电动汽车智能充电技术标准化工作取得重大进展，并将为世界电动汽车充电基础设施智能 化升级提供"中国方案"。 ★五部门联合发文 实施戏剧振兴三年行动计划 美股三大指数集体收涨，大型科技股多数上涨，热门中概股涨跌不一。操作上建议低吸参与为主。 2月9日，围绕加强重点液态食品道路散装运输管理，市场监管总局联合相关部门发布了多个制度文件。据 悉，此次发布的《实行道路散装运输许可制度的重点液态食品目录》《重点液态食品道路散装运输准运管 理办法》《重点液态食品道路散装运输联单管理工作规范》等制度文件，旨在贯彻落实党中央、国务院决 策部署 ...

【SynBioCon】 获 悉， 2月6日，专注于植物细胞底盘合成生物技术的 神笔生物 ，正式完成 数千万元Pre-A轮融资 ，由百联挚高独家领投。资金 将主要用于 " 植物细胞底盘合成生物平台的技术迭代、核心产品产业化落地及市场拓展 "。 神笔生物为人所知的标签，是其在2024年成功培育出的 国内首株高亮度、性状稳定的自发光植物 。 神笔生物 自发光植物 01 技术破壁：532次实验背后的"追光"之旅 据合肥在线2024年8月的报道，神笔生物团队为实现这一目标， 进行了长达一年多的研发，共经历了532次关键实验迭代 。 从最初需要长时间手机曝光才能捕捉到微弱光迹，到最终实现肉眼清晰可见的稳定亮度，每一次迭代都是对基因通路、转化效率和植物 性状的极致 优化。 关键词| 资本事件 | 神笔生物 此次融资的特别之处在于，它投向了一个将前沿基因编辑技术转化为 可见、可感、可消费 产品的企业。 其技术核心在于，将自然界中发光生物（如某些真菌或海洋生物）的 荧光素酶基因 ，通过基因编辑技术整合进植物的基因组。 这些外源基因在植物体内成功表达，催化一系列生化反应，最终将化学能转化为可见光，实现植物的"自发光"。 "这个数 ...

Core Insights - The biomanufacturing sector is gaining momentum with strong policy support and technological advancements, positioning it as a key future industry in China [1][2] - The market size of China's biomanufacturing industry is projected to reach approximately 1.8 trillion yuan by 2030, with significant contributions from food additives and biopharmaceuticals [1][2] Industry Developments - The Ministry of Industry and Information Technology has reported that during the 14th Five-Year Plan, China's biomanufacturing industry is expected to expand steadily, reaching a total scale of 1.1 trillion yuan, with bioproducts accounting for over 70% of global production [1] - The focus of the 14th Five-Year Plan is on the industrialization of technology, emphasizing pilot testing, process scaling, and demonstration line construction [2] Company Initiatives - Ruipu Biotech is investing 680 million yuan in a large-scale microbial protein industrialization demonstration project, aiming for trial production by Q4 2026 [3] - Fuxiang Pharmaceutical is leveraging its expertise in high-end antibiotic fermentation to enhance its microbial protein project, focusing on domestic and international expansion [4] - Yikela Biotech is targeting high-value aquatic feed proteins through a collaboration with Fudan University, aiming to reduce reliance on imported fishmeal [5] Technological Advancements - Synthetic biology is identified as a core technology driving low-carbon production and increased labor productivity across various sectors, including healthcare and industrial manufacturing [2] - The integration of AI with synthetic biology is expected to shift the competitive landscape from single-point breakthroughs to platform-based competition, enhancing R&D efficiency [7] Market Trends - The most promising sub-sectors in biomanufacturing during the 14th Five-Year Plan include high-value biomanufactured products in healthcare, bio-based materials, and service-oriented platforms [6] - The industry is anticipated to experience differentiation and improved quality as companies focus on scalable processes, cost control, and clear downstream applications [2][6]

专题：四大证券报精华 中国证券报 沪深北交易所推出优化再融资一揽子措施 2月9日，沪深北交易所推出优化再融资一揽子措施，旨在进一步提高灵活性和便利度，更好服务科技创 新和新质生产力发展。一揽子措施突出扶优、扶科、限劣导向，明确对优质上市公司进一步提高再融资 效率，优化未盈利创新企业再融资间隔期要求。为更好适应科技创新企业再融资需求，沪深交易所研究 推出主板上市公司"轻资产、高研发投入"认定标准。 市场监管总局发布多个制度文件 补齐液态食品散装运输管理制度短板 2月9日，围绕加强重点液态食品道路散装运输管理，市场监管总局联合相关部门发布了多个制度文件。 据悉，此次发布的《实行道路散装运输许可制度的重点液态食品目录》《重点液态食品道路散装运输准 运管理办法》《重点液态食品道路散装运输联单管理工作规范》等制度文件，旨在贯彻落实党中央、国 务院决策部署和新修改的食品安全法的规定要求，着力补齐液态食品散装运输管理制度的短板，不断提 升食品安全全链条监管水平。 AI需求激增 MLCC接棒内存上涨 AI引发的涨价潮正在元器件产业链蔓延。继存储芯片价格飙升后，片式多层陶瓷电容器（MLCC）成为 下一个涨价的关键元器件。据悉， ...

一份刚刚发布的三年行动方案，将重塑这座城市的产业版图，并将触角伸向近地轨道。 2025年，上海规上工业总产值跨越4万亿元大关，创下历史新高。在这个制造业强势复苏的基础上，上 海并未停下脚步。近日，上海市经济和信息化委员会牵头编制的《上海市支持先进制造业转型升级三年 行动方案（2026—2028年）》（下称《行动方案》）正式发布，设定了明确目标：到2028年，新增年产 值10亿元以上制造业企业100家，累计超过600家，并带动产业链新增规上工业企业500家。这个被称 为"10亿+"的企业集群，是上海工业经济的核心力量。 01 产业投资的强劲势头 强劲的投资为未来增长注入了信心。数据显示，2025年，上海工业投资同比增长20.0%。其中，作为核 心的制造业投资表现尤为亮眼，同比增长22.8%。这不仅体现了市场主体的预期，也为《行动方案》提 出的三年目标提供了坚实基础。 02 多路径的产业结构调优 《行动方案》提出了以四大行动、17条举措为核心的完整路径。其中，"结构调优升级行动"对不同能级 的产业给出了差异化方案。对于传统优势产业，方案强调"优化提升"。例如，推动石化企业向"去油增 化"转型，布局新型功能材料；钢 ...